Pnc Financial Services Group, Inc. Axsome Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,856 shares of AXSM stock, worth $259,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,856
Previous 1,749
6.12%
Holding current value
$259,264
Previous $182,000
23.63%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AXSM
# of Institutions
424Shares Held
37MCall Options Held
752KPut Options Held
567K-
Vanguard Group Inc Valley Forge, PA4.18MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...